Key result
Urinary proteomic profiling identifies a novel 6-protein panel for diagnosing carotid artery stenosis.
Case-Control
Answers are grounded in this paper and cite their sources.
Reveals novel urinary protein biomarkers for carotid artery stenosis diagnosis and risk stratification, indicating a noninvasive strategy for identifying high-risk stroke patients.
Background: Carotid artery stenosis (CAS) is caused by the formation of atherosclerotic plaques inside the arterial wall and accounts for 20–30% of all strokes. The development of an early, noninvasive diagnostic method and the identification of high-risk patients for ischemic stroke is essential to the management of CAS in clinical practice. Methods: We used the data-independent acquisition (DIA) technique to conduct a urinary proteomic study in patients with CAS and healthy controls. We identified the potential diagnosis and risk stratification biomarkers of CAS. And Ingenuity pathway analysis was used for functional annotation of differentially expressed proteins (DEPs). Furthermore, receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic values of DEPs. Results: A total of 194 DEPs were identified between CAS patients and healthy controls by DIA quantification. The bioinformatics analysis showed that these DEPs were correlated with the pathogenesis of CAS. We further identified 32 DEPs in symptomatic CAS compared to asymptomatic CAS, and biological function analysis revealed that these proteins are mainly related to immune/inflammatory pathways. Finally, a biomarker panel of six proteins (ACP2, PLD3, HLA-C, GGH, CALML3, and IL2RB) exhibited potential diagnostic value in CAS and good discriminative power for differentiating symptomatic and asymptomatic CAS with high sensitivity and specificity. Conclusions: Our study identified novel potential urinary biomarkers for noninvasive early screening and risk stratification of CAS.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) conducted a case-control in Carotid artery stenosis (CAS). Urinary proteomic profiling via data-independent acquisition (DIA) vs. Healthy controls and asymptomatic carotid artery stenosis was evaluated on Identification of differentially expressed proteins (DEPs) and diagnostic/discriminative performance of a urinary biomarker panel for carotid artery stenosis. Urinary proteomic profiling identified 194 DEPs versus controls, 32 DEPs in symptomatic versus asymptomatic CAS, and a 6-protein diagnostic panel (ACP2, PLD3, HLA-C, GGH, CALML3, IL2RB).
Synapse has enriched 10 related papers. Consider them for comparative context: